Histologically Proven Recurrent Synovitis after Nivolumab Treatment

  • Nakayama Yuki
    Nephrology Center and Okinaka Memorial Institute for Medical Research, Toranomon Hospital Kajigaya, Japan
  • Sawa Naoki
    Nephrology Center and Okinaka Memorial Institute for Medical Research, Toranomon Hospital Kajigaya, Japan
  • Suwabe Tatsuya
    Nephrology Center and Okinaka Memorial Institute for Medical Research, Toranomon Hospital Kajigaya, Japan
  • Yamanouchi Masayuki
    Nephrology Center and Okinaka Memorial Institute for Medical Research, Toranomon Hospital Kajigaya, Japan
  • Ikuma Daisuke
    Nephrology Center and Okinaka Memorial Institute for Medical Research, Toranomon Hospital Kajigaya, Japan
  • Mizuno Hiroki
    Nephrology Center and Okinaka Memorial Institute for Medical Research, Toranomon Hospital Kajigaya, Japan
  • Hasegawa Eiko
    Nephrology Center and Okinaka Memorial Institute for Medical Research, Toranomon Hospital Kajigaya, Japan
  • Sekine Akinari
    Nephrology Center and Okinaka Memorial Institute for Medical Research, Toranomon Hospital Kajigaya, Japan
  • Oba Yuki
    Nephrology Center and Okinaka Memorial Institute for Medical Research, Toranomon Hospital Kajigaya, Japan
  • Ishiwata Kazuya
    Department of Hematology, Toranomon Hospital Kajigaya, Japan
  • Wake Atsushi
    Department of Hematology, Toranomon Hospital Kajigaya, Japan
  • Hatano Masaki
    Department of Orthopaedic Surgery, Toranomon Hospital Kajigaya, Japan
  • Kitajima Izuru
    Department of Orthopaedic Surgery, Toranomon Hospital Kajigaya, Japan
  • Kono Kei
    Department of Pathology, Toranomon Hospital Kajigaya, Japan
  • Kinowaki Keiichi
    Department of Pathology, Toranomon Hospital Kajigaya, Japan
  • Takazawa Yutaka
    Department of Pathology, Toranomon Hospital Kajigaya, Japan
  • Takemura Tamiko
    Department of Pathology, Kanagawa Cardiovascular and Respiratory Center, Japan
  • Ubara Yoshifumi
    Nephrology Center and Okinaka Memorial Institute for Medical Research, Toranomon Hospital Kajigaya, Japan

抄録

<p>A 58-year-old woman with rheumatoid arthritis was diagnosed with methotrexate-associated Hodgkin lymphoma. After receiving several chemotherapy regimens, she started nivolumab treatment. Two weeks later, she was hospitalized with worsening finger, wrist, and elbow joint pain. A synovial biopsy of the wrist joint showed villous synovial proliferation and linear infiltration of CD68-/CD3-positive T cells (with more CD8 than CD4 T cells) but no CD20-positive B cells or CD138-positive macrophages. These findings corresponded to synovitis associated with immune-related adverse events, which are induced mainly by T cells and are different from typical rheumatoid arthritis (RA), in which B cells play a central role. </p>

収録刊行物

  • Internal Medicine

    Internal Medicine 63 (6), 867-871, 2024-03-15

    一般社団法人 日本内科学会

参考文献 (13)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ